Are drugs designed to work best for all patients?
Are randomised controlled trials achieving the results we need for patients? In the latest instalment of ERS Vision, Professor Elisabeth Bel leads a discussion on the relevance of real-life evidence and whether it can enhance existing guidelines.
The documentary considers how we can ask the right questions to provide the right solutions for each individual patient. Leading experts consider the value of this type of research, along with the issues surrounding quality standards, costs and how it can be effectively designed and applied.
European Respiratory Society: Should we be testing new drugs in the ‘real’ world where some patients smoke, are obese and have other comorbidities?
Share this post
Latest News posts
Assistance for Patients Who Cannot Afford Antifungal Drugs (US only)
February 15, 2019
How do I know that this research paper is any good?
February 15, 2019
Treat the Causes of Chronic Disease, Not the Symptoms
February 14, 2019
How do I describe symptoms to my doctor?
February 14, 2019
New Diagnostics Tool
February 7, 2019
Take a look around a mycology laboratory!
February 7, 2019
WHO WANTS TO LIVE FOREVER? by Elizabeth Hutton
January 30, 2019
‘I’M STILL STANDING – (ME ‘N ELTON!) by Elizabeth Hutton
January 30, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video